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Abstract: Development of micro- and nanotechnology for the study of living cells, especially 
in the field of drug delivery, has gained interest in recent years. Although several studies have 
reported successful results in the internalization of micro- and nanoparticles in phagocytic cells, 
when nonphagocytic cells are used, the low internalization efficiency represents a limitation 
that needs to be overcome. It has been reported that covalent surface modification of micro- and 
nanoparticles increases their internalization rate. However, this surface modification represents 
an obstacle for their use as drug-delivery carriers. For this reason, the aim of the present study 
was to increase the capability for microparticle internalization of HeLa cells through the use 
of noncovalently bound transfection reagents: polyethyleneimine (PEI) Lipofectamine™ 2000 
and FuGENE 6®. Both confocal microscopy and flow cytometry techniques allowed us to pre-
cisely quantify the efficiency of microparticle internalization by HeLa cells, yielding similar 
results. In addition, intracellular location of microparticles was analyzed through transmission 
electron microscopy and confocal microscopy procedures. Our results showed that free PEI at 
a concentration of 0.05 mM significantly increased microparticle uptake by cells, with a low 
cytotoxic effect. As determined by transmission electron and confocal microscopy analyses, 
microparticles were engulfed by plasma-membrane projections during internalization, and 
24 hours later they were trapped in a lysosomal compartment. These results show the potential 
use of noncovalently conjugated PEI in microparticle internalization assays.
Keywords: HeLa cells, internalization efficiency, endocytosis, drug delivery
Introduction
In the past decade, the fabrication of microelectromechanical systems with controlled 
physical and chemical properties in the micron and submicron scales has been of 
great interest in the biomedical field due to the high number of potential applications 
that they offer, such as the creation of biosensor systems, drug delivery systems, or 
therapeutic implants.1 In fact, fabrication of biological microelectromechanical sys-
tems for a wide range of applications, such as cell tracking,2 embryo tagging3 or drug 
delivery,4–6 has been achieved.
The application of biological microelectromechanical systems has acquired special 
importance due to their potential use in creating systems able to deliver a drug, in a 
controlled manner, to a specific target cell.7 The aforementioned studies have been suc-
cessful with use of phagocytic cells, but when nonphagocytic cells are used, their low 
capacity of internalization is still a limitation that has to be overcome. Moreover, it has 
been shown that several features of microparticle design play an important role in their 
uptake by cells: their size,8,9 shape,10,11 and surface properties.12 Several molecules have 
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been used to increase the capacity for microparticle uptake 
in nonphagocytic cells, in order to study the internalization 
process. In all cases, the microparticles were covalently modi-
fied with a selected molecule13–15 or coated with a bacterial 
membrane.16
Since it has been reported that positive-charged micropar-
ticles are more easily internalized by cells,11 the use of 
transfection procedures in microparticle internalization 
experiments could be considered as a possible approach to 
increase microparticle uptake when working with nonphago-
cytic cells. These procedures are based on the interaction 
between the positive charges of cationic polymers, like poly-
ethyleneimine (PEI) or cationic lipids, like LipofectamineTM 
2000 (LF2000), FuGENE®, or DOTAP, and the negative 
charges of DNA.17 The positive charges of the transfection 
reagents can also interact with the negatively charged oligo-
saccharides of the plasma membrane surface, facilitating the 
internalization of the complex by endocytosis. Once inside 
the cell, these reagents can disrupt the endocytic pathway, 
releasing the contents of the endosomes to the cytosol.18,19 In 
fact, the covalent binding of PEI to the microparticle surface 
facilitates their incorporation into HeLa cells.14,20 However, 
the modification of microparticles with covalently bound PEI 
would render difficult or even impede their functionaliza-
tion with other molecules, such as the drug to be delivered. 
Thus, a new strategy is necessary to improve microparticle 
uptake by nonphagocytic cells. In this sense, cationic lipids 
have been recently used as fusogenic agents to improve the 
internalization of polystyrene particles.21
Against this background, the aim of this study was to 
improve the efficiency of internalization of polystyrene 
microparticles by nonphagocytic (HeLa) cells through the use 
of the cationic polymer PEI and the cationic lipids LF2000 
and FuGENE 6 added to the culture medium as transfection 
agents. The internalization efficiency was evaluated using 
two completely different methods, confocal scanning laser 
microscopy (CSLM) and flow cytometry (FC), and took into 
account first, the cytotoxic effect of the transfection agent 
at one (LF2000) or three different concentrations (PEI), and 
second, the number of live, adhered cells with an internalized 
microparticle. Finally, the intracellular fate of microparticles 
was determined by immunogold labeling transmission elec-
tron microscopy (TEM) and by CSLM.
Materials and methods
Reagents
Unless otherwise stated, reagents were purchased from Life 
Technologies (Carlsbad, CA).
Polystyrene microparticles
Two types of polystyrene microparticles of 3µm   diameter 
were used: fluorescent microparticles  (Fluoresbrite® YG 
Microsphere 3 µm; Polysciences, Inc, Warrington, PA) and 
nonfluorescent carboxylated microparticles  (Polybead® Car-
boxylate Microspheres 3 µm;  Polysciences).  Nonfluorescent 
carboxylated microparticles were  functionalized with an 
Alexa Fluor® 594 conjugated goat anti-rabbit IgG antibody 
(H + L) (Life Technologies) using the PolyLink Protein 
Coupling kit (Polysciences), following the manufacturer’s 
recommendations.
Cell culture
HeLa cells were cultured at 37°C in a 5% CO
2
 atmosphere, 
using minimum essential medium (MEM) with Earle’s 
salts and L-Glutamine supplemented with 10% fetal bovine 
serum (FBS).
PEI, LF2000, and FuGENE 6  
cytotoxicity assay
The cytotoxicity of PEI 25 KDa (Sigma-Aldrich, St Louis, 
MO) used at three different concentrations (0.05, 0.10, and 
0.15 mM), of LF2000 (Life Technologies), and of FuGENE 6 
(Promega Corporation, Fitchburg, WI), used at the concen-
trations recommended by the manufacturers, was evaluated 
after the transfection procedure by assessing two different 
parameters: the percentage of cells that remained attached to 
the dish (normalized to the control group), and the viability 
of the attached cells. The global effect of the treatment was 
calculated by multiplying the normalized percentage of 
attached cells by the percentage of viable attached cells.
For the first parameter tested, ie, the percentage of cells 
that remained attached after the transfection procedure, 
1.5 × 105 HeLa cells were seeded in 35 mm diameter dishes 
(Nalge Nunc Int, Roskilde, Denmark). The next day, the 
transfection reagents at their respective concentrations 
were prepared and added to the cell cultures. Briefly, PEI 
10 mM was initially diluted with NaCl 150 mM, incubated 
at room temperature for 40 minutes, and then diluted to the 
three working concentrations (0.05, 0.10, and 0.15 mM) in 
MEM without serum. LF2000 and FuGENE 6 were prepared 
according to the manufacturer’s instructions, also in MEM 
without serum. The culture medium of HeLa cells was then 
replaced with the corresponding transfection solution, and 
the cells were incubated for 4 hours at 37°C and 5% CO
2
. 
After that, the transfection solutions were replaced with fresh 
culture medium. In the control culture, a 4-hour incubation 
with MEM without serum was performed. To determine the 
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number of cells that remained attached, cells were harvested 
24 hours later using 0.05% Trypsin-EDTA, centrifuged 
at 500 g for 5 minutes, and resuspended in fresh culture 
medium. Then, 50 µL of cell suspension was mixed with 
50 µL of Perfect-Count Microspheres™ CYT-PCM50 
(Cytognos SL, Salamanca, Spain) and counted in a Becton 
Dickinson FACSCanto II flow cytometer (BD Biosciences, 
Franklin Lakes, NJ) equipped with BD Biosciences FAC-
SDiva™ software, the beads and the cells being counted 
together. The cell concentration was obtained taking into 
account the concentration of Perfect-Count microspheres.
On the other hand, to evaluate cell viability after the transfec-
tion procedures, cells were seeded and incubated with the trans-
fection reagents, at the indicated concentrations. At 24 hours, 
attached cells were harvested as described, and their viability was 
determined by FC after applying the LIVE/DEAD® Viability/
Cytotoxicity Kit for mammalian cells (L3224; Life Technolo-
gies), according to the manufacturer’s instructions. The calcein 
acetomethoxy (AM) derivative of the kit diffuses through the 
cell membrane and, once inside the cell, it is converted to highly 
green fluorescent calcein by the intracellular esterases of living 
cells. The ethidium homodimer-1 of the kit can only enter cells 
with damaged membranes, being able to reach the nucleus and 
bind to DNA, which emits red fluorescence. Therefore, living 
cells are labeled with green fluorescence, whereas dead cells 
are labeled with red fluorescence.
Analysis of Zeta potential of polystyrene 
microparticles
The Zeta potential of microparticles in culture media before 
and after PEI, LF2000, and FuGENE 6 treatments, was 
measured using a Zetasizer Nano ZS (Malvern Instruments 
Malvern, UK).
Internalization of polystyrene 
microparticles in HeLa cells
To analyze the internalization of microparticles in HeLa cells, 
two approaches were carried out: CSLM (Fluoview® FV1000; 
Olympus Corp, Tokyo, Japan) and FC (previously described). 
For confocal microscope analysis, cells were seeded at a 
density of 1.5 × 105 cells/dish on 35 mm–diameter gridded 
glass-bottom coverslip dishes (MatTek Corp,  Ashland, MA). 
For FC analysis, cells were seeded at a density of 1.2 × 106 
cells/flask on 75 cm2 flasks (Nunc). After 24 hours of incuba-
tion, transfection was performed as described in the previous 
section. But, in this case, transfection solutions were mixed 
with 3 µm diameter polystyrene fluorescent microparticles at 
a final concentration of 106 microspheres/mL. The  efficiency 
of internalization of microparticles by HeLa cells was 
 determined 24 hours later.
For FC analyses, cells were harvested as mentioned above 
and microparticle–cell association was analyzed measuring 
the forward scatter and the fluorescent intensity.
For CSLM analyses, cells were washed twice with 
phosphate-buffered saline (PBS) for 5 minutes, and fixed 
with 4% paraformaldehyde (Sigma-Aldrich). Then, cells 
were washed thrice with PBS, blocked with 1% bovine serum 
albumin ([BSA] Sigma-Aldrich) in PBS, and finally stored 
at 4°C until their analysis. Samples were first examined 
under a phase contrast inverted microscope (Olympus IX71, 
Olympus, Hamburg, Germany) to determine the percentage 
of cells that were in contact with one or more microparticles. 
Thus, several fields were captured and then analyzed using 
image analysis software (ImageJ version 1.43r; National 
Institutes of Health, Bethesda, MD). Two hundred cells per 
sample were evaluated for each treatment, and 484 cells in 
the case of the control group. Following this preliminary 
assessment, the location of microparticles (ie, inside the cells 
or attached to their plasma membrane) was determined using 
CSLM. With this aim, cells were stained with wheat germ 
agglutinin conjugated to Texas Red (10 µg/mL; Life Tech-
nologies) and counterstained with  Hoescht 33258 (1 µg/mL; 
Sigma-Aldrich), to visualize the plasma membrane and the 
nucleus, respectively. Samples were then examined under 
the CSLM using a 63 × oil immersion objective, where 
x-y-z sequential acquisition was performed and orthogonal 
projections of the stacks were analyzed to determine the 
location of the microparticles within the cell. For the image 
analyses, the FV10-ASW Application Software (Ver. 01.07c; 
Olympus) was used.
The use of gridded dishes allowed us to examine the 
same fields in both microscopic evaluations (ie, inverted 
microscope and CSLM).
Electron microscopy
To analyze the intracellular location of microparticles, 
 transfected cells (as described in above) were fixed with 2.5% 
glutaraldehyde in phosphate buffer (PB). After 1 hour of incu-
bation with the fixative at 4°C, they were washed with PB and 
postfixed with 1% osmium tetroxide in PB containing 0.8% 
potassium ferricyanide at 4°C. Next, samples were dehydrated 
in acetone, infiltrated with Epon™ (Electron Microscopy 
Sciences, Hatfield, PA) resin over 2 days, embedded in the 
same resin, and polymerized at 60°C over 48 hours. Ultrathin 
sections were obtained using a Leica Ultracut UC6 ultramicro-
tome (Leica Microsystems, Wetzlar, Germany) and mounted 
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on Formvar-coated copper grids. They were stained with 2% 
uranyl acetate in water and lead citrate. Finally, sections were 
observed in an electron microscope (J1010; Jeol Ltd, Tokyo, 
Japan) equipped with a CCD camera SIS Megaview III.
Lysosome associated membrane  
protein 1 (LAMP-1) immunogold
After microparticle internalization using PEI 0.05 mM 
treatment, HeLa cells were chemically fixed at 4°C with a 
mixture of 4% paraformaldehyde and 0.1% glutaraldehyde 
in PB. After washing with PB containing 50 mM glycine, 
cells were embedded in 12% gelatine and infused in 2.3 M 
sucrose. Mounted gelatine blocks were frozen in liquid 
 nitrogen. Thin sections were prepared in an EM Ultracut 
UC6/FC6 ultracryomicrotome (Leica Microsystems, Wetzlar, 
Germany).  Ultrathin cryosections were collected with 2% 
methylcellulose in 2.3 M sucrose.
Cryosections were incubated at room temperature on drops 
of 2% gelatine in PBS for 20 minutes at 37°C,  followed by 
50 mM glycine in PBS for 15 minutes, 10% FBS in PBS for 
10 minutes, and 5% FBS in PBS for 5 minutes. Then they 
were incubated with 5 µL of rabbit anti-LAMP-1  polyclonal 
antibody (Abcam, Cambridge, UK) for 30 minutes. After 
three washes on drops of PBS for 10 minutes, sections were 
incubated for 20 minutes using colloidal gold conjugated goat 
anti-rabbit IgG (cat. 111-205-144) Jackson Immunoresearch 
Laboratories Inc, West Grove, PA) using a 1:30 dilution in 
5% FBS/PBS. This was followed by three washes on drops of 
PBS for 10 minutes, and two washes with distilled water. As a 
control for nonspecific binding of the colloidal gold conjugated 
antibody, the primary antibody was omitted.
The observations were done in an electron microscope 
(Jeol) with a CCD camera SIS Megaview III.
Early endosome antigen 1 protein 
(EEA-1) and LAMP-1 immunolabeling
To visualize the location of the microparticles 24 hours after 
the transfection procedure, cells were seeded at a density of 
1.5 × 105 cells/dish on 35 mm–diameter gridded glass-bottom 
coverslip dishes (MatTek Corp). After 24 hours of  incubation, 
transfection with PEI 0.05 M mixed with 3 µm diam-
eter polystyrene functionalized microparticles (previously 
described) at a final concentration of 106 microspheres/mL 
was performed as described above. After 24 hours, cells were 
washed twice with PBS fixed in 4% paraformaldehyde/PBS, 
permeabilized with 0.25% Triton X-100 in PBS, and blocked 
with 5% PBS/BSA. Then, cells were incubated for 1 hour at 
37°C with one of two primary antibodies, mouse anti-EEA-1 
monoclonal antibody (cat. 610456 BD Biosciences) or mouse 
anti-LAMP-1 polyclonal antibody (cat. 555798 BD Biosci-
ences), to label the endosomal or the lysosomal compartment, 
respectively. Finally, cells were incubated for 1 hour at room 
temperature with Alexa 488-conjugated chicken anti-mouse 
IgG antibody (Life Technologies), counterstained with Hoe-
scht 33258, and analyzed by CSLM. For each marker, 40 cells 
with microparticles were analyzed.
Statistical analyses
Normal distribution of data was verif ied with the 
 Kolmogorov–Smirnov test, and homoscedasticity was assessed 
with the Levene’s test. When necessary, data (x) on percent-
ages were transformed with arcsin square root transformation 
(arcsin√x) for accomplishing the parametric assumptions. The 
comparison among the different treatments was done with a 
one-way analysis of variance (ANOVA), followed by a posthoc 
t-test with Bonferroni’s correction for multiple comparisons. P 
, 0.05 was considered to be statistically significant.
Results
Cytotoxic effect of transfection reagents
The percentage of cells that remained attached to the dish after 
the transfection procedures can be seen in Figure 1A, show-
ing that all treatments resulted in a significant decrease in the 
percentage of attached cells. Normalized to the control group, 
PEI 0.05 mM was the less aggressive treatment (77.4% of cells 
remaining attached) when compared with the rest of the treat-
ments (47.5%, 36.5%, 20.8%, and 20.1% for PEI 0.10 mM, 
FuGENE 6, LF2000, and PEI 0.15 mM, respectively).
The viability of the attached cells was determined by 
calcein AM/ethidium homodimer-1staining. Figure 1B shows 
that after PEI 0.10 mM and 0.15 mM treatments, the per-
centages of living cells were significantly lower (65.6% and 
62.5%, respectively) than those observed following the other 
treatments (94.7% [control], 94.1% [FuGENE 6], 90.4% [PEI 
0.05 mM], and 87.6% [LF2000]). Moreover, the difference 
between control and LF2000 was also significant.
When both parameters are considered (Figure 1C), 
PEI 0.05 mM appears as the least cytotoxic treatment, with 70% 
of cells remaining viable; whereas in the other treatments, less 
than 35% of the cells remained alive (34.3% FuGENE 6; 31.2% 
PEI 0.10 mM; 12.6% PEI 0.15 mM; and 18.2% LF2000).
Effect of transfection reagents  
on microparticle surface charge
To evaluate the electrochemical changes at the microparticle 
surface due to the treatment with the transfection reagents, 
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C
Figure 1 Cytotoxicity of transfection treatments. (A) Percentage of cells that remained attached to the dish after treatments, normalized to the control. (B) Percentage of 
viable attached cells after treatments. (C) Percentage of viable cells.
Note: a, b, c denote significant differences among groups.
Abbreviations: PEI, polyethyleneimine; LF, Lipofectamine™. 
their Z potential was analyzed. As can be seen in Figure 2, 
nontreated fluorescent microparticles showed a highly 
negative Z potential (-45.9), whereas treatment with the 
transfection reagents clearly changed the surface to posi-
tively charged. This change also occurred in functionalized 
microparticles after PEI 0.05 treatment.
Internalization of polystyrene 
microparticles by HeLa cells
Microparticle internalization by HeLa cells was evaluated 
by two approaches, FC and CSLM. By FC, it was observed 
that for all treatments, the number of cells in contact 
with microparticles was clearly increased from twofold 
(PEI 0.15 mM) to fivefold (PEI 0.05 mM) when compared 
with the control (Figure 3). In addition, for all treatments, in 
the population of cells associated with microparticles, there 
were no differences among the percentages of cells with one, 
two, three, or more microparticles (Figure 4).
Confocal microscopy analyses were performed next to 
precisely determine whether microparticles were located 
inside or outside the cells (Figure 5A and B). As can be seen 
in Figure 5C, in the cells that remained attached to the dish, 
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Figure 2 Z potential of control microparticles and of microparticles treated with PEI, LF2000 and FuGENE 6®. 
Note: The Zeta potential of the functionalized microparticle is also shown. 



































Figure 3 Flow cytometry analysis. Percentage of cells in contact with at least one microparticle. 
Notes: a, b, c, d denote significant differences among groups.
Abbreviations: PEI, Polyethyleneimine; LF, Lipofectamine™. 
a significant increase (P , 0.05) in the percentage of cells 
in contact with microparticles and in the percentage of cells 
with internalized microparticles was observed for all treat-
ments compared with the control group, these results being 
consistent with those previously obtained by FC.
Finally, the results obtained from FC and CSLM analyses 
were compared taking into account the cytotoxic effect of 
the different treatments (see Figure 1C). Figure 6 shows that 
PEI 0.05 mM provided the highest microparticle internaliza-
tion efficiency, doubling at least the efficiency of the other 
treatments.
Internalization of functionalized 
polystyrene microparticles by HeLa cells
To test whether PEI 0.05 mM could also enhance micropar-
ticle internalization when a cargo is covalently attached to 
their surface, the internalization efficiency of antibody-
functionalized microparticles was determined by CSLM. 
This analysis showed that 18.9% of the cells had internal-
ized at least one functionalized microparticle, a percentage 
equivalent to that for non-functionalized microparticles 
(25.5%) and significantly higher than that for the control 
group (3.7%).
Intracellular location of microparticles
To investigate the intracellular fate of microparticles, TEM 
analyses were carried out in Epon-embedded samples. 
According to the previous results, only the PEI 0.05 mM 
treatment was selected for these analyses. A plasma membrane 
evagination was clearly observed around microparticles whilst 
they were being engulfed by HeLa cells (Figure 7A). Once 
internalized, microparticles appeared to be tightly surrounded 
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Figure 4 Flow cytometry analysis. Transfection agents’ effect on the internalization of fluorescent microparticles by HeLa cells. (A), (C), (E), (G), (I) and (K) Dot plots 
showing two populations of cells: associated (cells + MP) or not associated (cells) with green fluorescent microparticles. (B), (D), (F), (H), (J) and (L) Histograms showing 
the fluorescence intensity of the different populations of cells.
Notes: Cells = cell population not associated with microparticles. Cells + MP = cell population associated with at least one microparticle. P2, P3, P4, P5 = cell population 
associated with one, two, three, or more than three microparticles, respectively.
Abbreviations: MP, microparticle; PEI, polyethyleneimine; LF, Lipofectamine™.
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PEI 0.05 mM PEI 0.10 mM PEI 0.15 mM LF2000 FuGENE
% cells with attached MPs
% cells with internalized MPs
Figure 5 CSLM analyses of microparticle location. (A and B) CSLM-obtained images (middle) and their orthogonal projections of the z-stack reconstructions (right and 
bottom) of consecutive focal planes (0,5 μm each). (C) Percentage of cells in contact with microparticles, either attached or internalized, analyzed by CSLM.
Notes: Green arrows indicate a microparticle located inside the cell, clearly surrounded by the plasma membrane. The red arrow points to a microparticle attached to the 
plasma membrane but outside the cell. Plasma membrane appears in red (WGA-Texas Red® Staining) and chromatin in blue (Hoescht 33258).































Figure 6 Microparticle internalization efficiency. Percentage of viable cells with one or more internalized microparticles after the different transfection treatments.
Notes: Results were obtained from internalization analyses by both CSLM and FC, taking into account the number of cells that remained attached to the dish after treatments 
and their viability.
Abbreviations: CSLM, confocal scanning laser microscopy; FC, flow cytomtery; PEI, polyethyleneimine; LF, Lipofectamine™.
by a single membrane in the majority of cases  (Figure 7B), 
and occasionally, they were additionally surrounded by a 
two-membrane complex (Figure 7C and D).
The immunolocalization of LAMP-1 showed that in the 
majority of cells analyzed, the membrane surrounding the 
microparticles was positive for LAMP-1, indicating that 
microparticles were trapped in a lysosomal compartment 
(Figure 8).
To quantify the number of internalized microparticles 
located inside lysosomes, CSLM analysis using two cell 
compartment markers (EEA-1 for endosomes and LAMP-1 
for lysosomes) was carried out. In this case, antibody-
functionalized microparticles were used because their lower 
fluorescence intensity in relation to fluorescent microparticles 
allowed us to observe the colocalization of the internalized 
microparticles and the endosomal/lysosomal compartments. 
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Figure 7 Microparticle localization by transmission electron microscopy. 
Micrographs of HeLa cells with internalized microparticles. (A) Illustration of the 
internalization of microparticles; arrow indicates a cell membrane evagination, 
typical of macropinocytosis. (B) A single membrane surrounding an internalized 
microparticle. (C) Microparticle surrounded by a double membrane. (D) Enlarged 
view of the microparticle shown in C.
Notes: Arrow heads point to a single membrane tightly associated to microparticle. 
Arrows indicate the two membrane complex. Scale bars: (A) 2 µm (B) 1 µm (C) 











Figure 8 LAMP-1 immunogold detection. Cryotransmission electron micrographs 
of LAMP-1 immunogold performed in HeLa cells. (A–C) Arrow heads indicate 
positive LAMP-1 marks. (D) Arrow heads indicate positive LAMP-1 marks whereas 
arrows point to the lysosome membrane.
Abbreviation: LAMP-1, lysosome associated membrane protein 1; L, lysosome.
It was observed that 24 hours after treatment, none of the 
microparticles colocalized with endosomes and 83.4% colo-
calized with lysosomes, confirming the results previously 
obtained by TEM.
Discussion
The use of micro- and nanoparticles as carriers for drug 
delivery applications has gained interest in recent years.7 It 
has been shown that their uptake by cells is highly dependent 
on their physical and chemical properties, especially their 
size and surface charge (being that cationic particles are 
more easily uptaken by cells).11 However, the low capacity 
of nonphagocytic cells for the internalization of micron-sized 
particles is a handicap that needs to be improved.
In order to increase microparticle uptake by nonphagocytic 
cells, PEI, LF2000, and FuGENE 6 were chosen because of 
their efficiency in DNA transfection procedures. Moreover, 
PEI and LF2000 have also been used in microparticle-14,20,21 
and nanoparticle-internalization22 experiments.
In our study, we analyzed the effect of free PEI (ie, 
noncovalently bound to microparticle surface) on the 
microparticle-internalization efficiency. Considering that 
these microparticles are expected to be drug-delivery carri-
ers in the future and that the cargo will need to be attached 
to their surface, we considered the use of free PEI as a more 
appropriate approach to avoid competition for the same 
substrate. To the best of our knowledge, this is the first time 
that free PEI has been used for internalizing microparticles. 
In this regard, although PEI, LF2000, and FuGENE 6 have 
been widely used in DNA transfection procedures with 
positive results, it has been described that they produce a 
considerable cytotoxic effect, which has to be taken into 
account.18,23 Thus, with the aim of finding the best balance 
between efficiency of microparticle internalization and cyto-
toxicity, three different concentrations of PEI were tested 
in the present study. The highest concentration was set at 
0.15 mM since it has been reported that an intense cytotoxic 
effect is observed at higher concentrations.24 In the case of 
LF2000 and FuGENE 6, the concentrations used were those 
recommended by the manufacturers, which provided good 
results when used for internalizing 1 or 3 µm–sized beads 
in the case of LF2000.21
In our study, the number of cells remaining attached to 
the culture plates after their exposure to the transfection 
reagents was determined, together with the viability of these 
attached cells. This combined analysis allowed us to more 
accurately determine the cytotoxic effect of the treatments. 
We observed that compared with the control culture, the per-
centage of viable cells among those attached was high in all 
treatments (more than 60% viable cells), but a reduction in the 
percentage of attached cells was observed for all  treatments. 
These data demonstrate the usefulness of taking into account 
not only the viability of the cells but also the percentage of 
remaining cells after treatments in the cytotoxicity assays and 
moreover, showed that PEI at 0.05 mM was the least cyto-
toxic treatment. On the other hand, our viability results are in 
agreement with previous reports in that free PEI treatments 
produced a dose-dependent  cytotoxic effect.25 None of the 
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reported studies that used LF2000 to improve microparticle 
uptake21,26 analyzed the cytotoxic effect of this agent.
To calculate the efficiency of microparticle uptake, two 
different strategies were used. FC studies allowed us to clearly 
identify the population of cells associated with microparticles 
but also to discriminate among cells associated with one or 
more microparticles. The results obtained by FC showed that 
all treatments increased the percentage of cells associated 
with microparticles, especially PEI 0.05 mM (25.9%) and 
LF2000 (20.4%). Furthermore, no significant differences 
were found between these two treatments, indicating that both 
would be equally efficient in terms of microparticle inter-
nalization. In the case of PEI, a decrease in the percentage 
of cells in contact with microparticles was observed as PEI 
concentration was increased. However, FC did not allow us 
to distinguish between internalized microparticles and those 
only bound to the cell surface.
To complement the FC data and to determine the location 
of microparticles, confocal analyses of cells were performed. 
By confocal microscopy, it was possible to discriminate and 
quantify the number of microparticles that had been internal-
ized or that were only in contact with the cell surface. With 
regards to the use of LF2000, our results are in agreement 
with those of Kobayashi et al,21 who reported an increase 
in the rate of internalization of 1 µm–sized microparticles 
by HeLa cells when using this reagent. On the other hand, 
and concerning the use of PEI, the data obtained in the 
present study agree with previous studies, such as that of 
Thiele et al,14 who demonstrated that microparticles cova-
lently bound to PEI are more efficiently internalized by 
macrophages and dendritic cells than are microparticles 
alone. In the present study, we demonstrated that PEI could 
also increase microparticle internalization in nonphagocytic 
cells, and that this could be accomplished without its covalent 
attachment to the microparticle surface. In addition, we 
observed a dose-dependent, inverse relationship between PEI 
concentration and internalization efficiency. In agreement 
with FC, quantification by CSLM indicated that increasing 
concentrations of PEI not only resulted in an increase in the 
number of microparticles in contact with cells, but also in a 
decreased internalization. Our results suggest that the lower 
internalization rates at higher PEI concentrations could be 
related to its higher cytotoxic effect, especially membrane 
damage,27,28 which would lead to an incapability of the 
affected cells for microparticle internalization.
The higher efficiency of microparticle internalization 
after their treatment with a transfection reagent seems to 
be related to the changes in surface charges, as determined 
by the results of the Z potential analysis. Our results also 
showed that although surface properties of the microparticles 
were modified after the antibody conjugation, PEI could still 
interact with them, increasing their uptake by cells without 
affecting the fluorescence emission of the functionalizing 
molecule.
Both FC and CSLM analyses showed that, when the 
cytotoxic effect of the transfection reagents is considered, PEI 
0.05 mM turns out to have been the most effective treatment, 
since it led to at least a twofold increased  microparticle inter-
nalization rate. The advantage of FC was the high number 
of cells that could be analyzed in a short period of time, 
whereas the advantage of CSLM was its ability to ascertain 
internalization.
Considering that microparticles are expected to deliver 
their cargo inside the cell, it is necessary to determine 
their exact location inside the cell. Our results, using TEM 
analyses, showed that they were engulfed by a cell membrane 
Figure 9 Intracellular location analysis of functionalized microparticles by CSLM. (A) Endosomal labeling with EEA-1. (B) Lysosomal labeling with LAMP-1. (C and D) 
Microparticles functionalized with an Alexa Fluor®-594 conjugated antibody. (E and F) Merged images of compartment and microparticles.
Abbreviations: CSLM, confocal scanning laser microscopy; EEA-1, early endosome antigen 1 protein; LAMP-1, lysosome associated membrane protein 1.





International Journal of Nanomedicine 2012:7
evagination and no discernible coat was visible. We also 
observed that once inside the cell, they appeared to be tightly 
surrounded by a single membrane, positive for the LAMP-1 
lysosome marker, indicating that after 24 hours, the majority 
of microparticles were entrapped in lysosomes. These results 
have been confirmed by the use of nonfluorescent micropar-
ticles functionalized with an Alexa 594-conjugated secondary 
antibody, as the majority of internalized microparticles were 
also localized in the lysosomal compartment. We anticipated 
that using PEI, microparticles would be found in the cytosol, 
because it has been previously reported that the capability of 
protonation of PEI results in the disruption of endosomes.29–31 
Authors that have covalently attached PEI to microparticles20 
have reported that these particles can be found free in the 
cytosol as early as 4–6 hours  posttransfection when using PEI 
70 KDa but not when using PEI 25 KDa. Kobayashi et al21 
demonstrated that the use of free cationic lipids increases the 
internalization of microparticles and that once in the endo-
somes compartment, they escape in a few  minutes. According 
to this author, the rupture of the endosome membrane induces 
the formation of an autophagosome. In our study by TEM, we 
found that a few microparticles were surrounded by a double 
membrane, which could correspond to endoplasmic reticulum, 
indicating that an autophagic  process was taking place. Our 
results regarding the intracellular location of microparticles 
by CSLM confirmed the results of the TEM studies, indicating 
that in the majority (83.4%) of cells, the internalized micropar-
ticles were located in the lysosomal compartment. As no 
endosomal association with microparticles was observed, the 
microparticles that were not located in lysosomes could be 
either free in the cytosol, or part of an autophagic process. 
Further studies will be necessary to analyze whether, when 
microparticles are functionalized with a specific cargo, the 
cargo can be released into the cytosol even if the microparticle 
remains trapped inside an organelle.
Conclusion
To sum up, our results show that PEI 25 kDa at a concen-
tration of 0.05 mM significantly increases microparticle 
internalization by nonphagocytic HeLa cells with a low 
cytotoxic effect, and that this can be achieved without the 
covalent binding of PEI to the microparticle surface. Both 
CSLM and FC can be used for the quantification of internal-
ization efficiency, yielding similar results, but FC allows a 
fast analysis of high numbers of cells whereas CSLM allows 
distinction between cells with internalized microparticles and 
cells with microparticles attached to their surface. Finally, 
our results show that 0.05 mM PEI 25 kDa does not induce 
endosomal disruption, as internalized microparticles remain 
surrounded by a lysosomal membrane. With a view to drug 
delivery, further studies will be necessary to evaluate whether 
functionalized microparticles entrapped in lysosomes are still 
able to release their cargo into the cytosol.
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